These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19123835)

  • 1. Mechanism of hydrogen peroxide production by copper-bound amyloid beta peptide: a theoretical study.
    Hewitt N; Rauk A
    J Phys Chem B; 2009 Jan; 113(4):1202-9. PubMed ID: 19123835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abeta-mediated ROS production by Cu ions: structural insights, mechanisms and relevance to Alzheimer's disease.
    Hureau C; Faller P
    Biochimie; 2009 Oct; 91(10):1212-7. PubMed ID: 19332103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction.
    Huang X; Atwood CS; Hartshorn MA; Multhaup G; Goldstein LE; Scarpa RC; Cuajungco MP; Gray DN; Lim J; Moir RD; Tanzi RE; Bush AI
    Biochemistry; 1999 Jun; 38(24):7609-16. PubMed ID: 10386999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper-binding amyloid precursor protein undergoes a site-specific fragmentation in the reduction of hydrogen peroxide.
    Multhaup G; Ruppert T; Schlicksupp A; Hesse L; Bill E; Pipkorn R; Masters CL; Beyreuther K
    Biochemistry; 1998 May; 37(20):7224-30. PubMed ID: 9585534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble amyloid beta1-28-copper(I)/copper(II)/Iron(II) complexes are potent antioxidants in cell-free systems.
    Baruch-Suchodolsky R; Fischer B
    Biochemistry; 2008 Jul; 47(30):7796-806. PubMed ID: 18598056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper transfer from Cu-Abeta to human serum albumin inhibits aggregation, radical production and reduces Abeta toxicity.
    Perrone L; Mothes E; Vignes M; Mockel A; Figueroa C; Miquel MC; Maddelein ML; Faller P
    Chembiochem; 2010 Jan; 11(1):110-8. PubMed ID: 19937895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling of zinc and copper binding with Alzheimer's amyloid beta-peptide.
    Han D; Wang H; Yang P
    Biometals; 2008 Apr; 21(2):189-96. PubMed ID: 17629774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cu(II) binding to monomeric, oligomeric, and fibrillar forms of the Alzheimer's disease amyloid-beta peptide.
    Karr JW; Szalai VA
    Biochemistry; 2008 Apr; 47(17):5006-16. PubMed ID: 18393444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrochemical and conformational consequences of copper (Cu(I) and Cu(II)) binding to beta-amyloid(1-40).
    Brzyska M; Trzesniewska K; Wieckowska A; Szczepankiewicz A; Elbaum D
    Chembiochem; 2009 Apr; 10(6):1045-55. PubMed ID: 19263448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox chemistry of copper-amyloid-beta: the generation of hydroxyl radical in the presence of ascorbate is linked to redox-potentials and aggregation state.
    Guilloreau L; Combalbert S; Sournia-Saquet A; Mazarguil H; Faller P
    Chembiochem; 2007 Jul; 8(11):1317-25. PubMed ID: 17577900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic studies of Cu(II) binding to amyloid-beta peptides and the fluorescence and redox behaviors of the resulting complexes.
    Maiti NC; Jiang D; Wain AJ; Patel S; Dinh KL; Zhou F
    J Phys Chem B; 2008 Jul; 112(28):8406-11. PubMed ID: 18570397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
    Tõugu V; Karafin A; Palumaa P
    J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics study of the beta amyloid peptide of Alzheimer's disease and its divalent copper complexes.
    Raffa DF; Rauk A
    J Phys Chem B; 2007 Apr; 111(14):3789-99. PubMed ID: 17388547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding affinities for models of biologically available potential Cu(II) ligands relevant to Alzheimer's disease: an ab initio study.
    Rickard GA; Gomez-Balderas R; Brunelle P; Raffa DF; Rauk A
    J Phys Chem A; 2005 Sep; 109(37):8361-70. PubMed ID: 16834228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling copper binding to the amyloid-β peptide at different pH: toward a molecular mechanism for Cu reduction.
    Furlan S; Hureau C; Faller P; La Penna G
    J Phys Chem B; 2012 Oct; 116(39):11899-910. PubMed ID: 22974015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems.
    Baruch-Suchodolsky R; Fischer B
    Biochemistry; 2009 May; 48(20):4354-70. PubMed ID: 19320465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alanine-2 carbonyl is an oxygen ligand in Cu2+ coordination of Alzheimer's disease amyloid-beta peptide--relevance to N-terminally truncated forms.
    Drew SC; Masters CL; Barnham KJ
    J Am Chem Soc; 2009 Jul; 131(25):8760-1. PubMed ID: 19496610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygen activation by the noncoupled binuclear copper site in peptidylglycine alpha-hydroxylating monooxygenase. Reaction mechanism and role of the noncoupled nature of the active site.
    Chen P; Solomon EI
    J Am Chem Soc; 2004 Apr; 126(15):4991-5000. PubMed ID: 15080705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Terminal deletions modify the Cu2+ binding site in amyloid-beta.
    Karr JW; Akintoye H; Kaupp LJ; Szalai VA
    Biochemistry; 2005 Apr; 44(14):5478-87. PubMed ID: 15807541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural studies of the Alzheimer's amyloid precursor protein copper-binding domain reveal how it binds copper ions.
    Kong GK; Adams JJ; Harris HH; Boas JF; Curtain CC; Galatis D; Masters CL; Barnham KJ; McKinstry WJ; Cappai R; Parker MW
    J Mol Biol; 2007 Mar; 367(1):148-61. PubMed ID: 17239395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.